Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy‐induced ovarian function failure

The DATA study (NCT00301457) compared 6 and 3 years of anastrozole in postmenopausal women with hormone receptor‐positive early breast cancer after 2–3 years of tamoxifen. Patients with chemotherapy‐induced ovarian function failure (CIOFF) were also eligible, but could be at risk of ovarian function...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Cancer
Main Authors: van Hellemond, Irene E.G., Vriens, Ingeborg J.H., Peer, Petronella G.M., Swinkels, Astrid C.P., Smorenburg, Carolien H., Seynaeve, Caroline M., van der Sangen, Maurice J.C., Kroep, Judith R., de Graaf, Hiltje, Honkoop, Aafke H., Erdkamp, Frans L.G., van den Berkmortel, Franchette W.P.J., de Boer, Maaike, de Roos, Wilfred K., Linn, Sabine C., Imholz, Alexander L.T., Tjan‐Heijnen, Vivianne C.G.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Cancer Therapy and Prevention
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6590217/
https://ncbi.nlm.nih.gov/pubmed/30588619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.32093
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados